A nanoparticle delivery system was used to transport antibody-based immunotherapeutic drugs in trials synchronize in the cancer cell in vitro cultures and in animal models.
An adeno-associated viral (AAV) vector was used to deliver a modified version of the CRISPR/Cas9 gene-editing tool to liver cells in a mouse model, which